|4Mar 2, 4:01 PM ET

CorMedix Inc. 4

4 · CorMedix Inc. · Filed Mar 2, 2017

Insider Transaction Report

Form 4
Period: 2017-03-01
ARMSTRONG JR. JOHN L.
Exec VP of Tech Operations
Transactions
  • Award

    Stock Option (Right to Buy Common Stock)

    2017-03-01+100,000100,000 total
    Exercise: $2.18Exp: 2027-03-01Common Stock (100,000 underlying)
Holdings
  • Restricted Stock Units

    Exp: 2027-02-28Common Stock (36,057 underlying)
    36,057
  • Stock Option (Right to Buy Common Stock)

    Exercise: $1.52Exp: 2024-11-14Common Stock (10,000 underlying)
    10,000
  • Stock Option (Right to Buy Common Stock)

    Exercise: $3.25Exp: 2025-07-28default (15,000 underlying)
    15,000
  • Stock Option (Right to Buy Common Stock)

    Exercise: $2.51Exp: 2026-03-08Common Stock (200,000 underlying)
    200,000
Footnotes (5)
  • [F1]The option vests based on certain performance milestones, subject to continued employment. The option will be forfeited if such milestones are not met by certain dates.
  • [F2]Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. The restricted stock units vest 50% on December 31, 2017 and 50% on December 31, 2018, subject to continued employment.
  • [F3]These options vested upon the achievement of certain milestones, subject to continued employment.
  • [F4]One third of these options vested upon the achievement of a certain milestone and one third vested on each of December 31, 2015 and July 28, 2015.
  • [F5]15,000 of these options vest monthly over four years, beginning on March 9, 2016, 20,000 vest upon the achievement of a certain milestone, subject to continued employment, and the rest vested upon the achievement of certain milestones.

Documents

1 file
  • 4
    issuerdirect_section16.xmlPrimary

    PRIMARY DOCUMENT